Mesenchymoangioblast-derived mesenchymal stem cells Completed Phase 1 Trials for Graft Versus Host Disease (cGvHD) Treatment

Indications	Status	Purpose	Phase
DBCOND0118738 (Graft Versus Host Disease (cGvHD))	Completed	Treatment	1

clinicaltrials.gov Identifier	Title	Drugs
NCT02923375	A Study of CYP-001 for the Treatment of Steroid-Resistant Acute Graft Versus Host Disease	Mesenchymoangioblast-derived mesenchymal stem cells (DB15739)